Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analysis
Merck to move COVID-19 treatment into large trials, sees sales recovering this year
Merck & Co on Friday said it plans to advance an antiviral treatment for COVID-19 into large studies in the coming weeks, and it forecast a more limited hit to full-year sales and profit from coronavirus lockdowns than it...
More Must read
Stock Pick
Merck and Company : Leader in oncology, modest valuation
With $46 billion in expected revenue this year, the American company Merck ranks sixth among the world's major pharmaceutical groups, behind J&J .
More Recommendations
Stock Trading Strategies
MERCK & CO., INC. - 10/14
The underlying trend is to the upside
BUY
MERCK & CO., INC. - 08/03
Buyers are coming back
BUY
MERCK & CO., INC. - 05/26
The trend should regain control
BUY
MERCK & CO., INC - 04/14
In an accumulation phase
BUY
MERCK & CO., INC - 03/26
Good timing to go long again
BUY
More Stock Trading Analysis
Upcoming event on MERCK & CO., INC.